Real-World KRd Results Comparable to Phase 3 Trial Results in Myeloma

by | Mar 14, 2025 | Clinical Trials | 0 comments

​ 

Carfilzomib, lenalidomide, and dexamethasone results from the real world continued to show effective responses and a tolerable safety profile.

 Carfilzomib, lenalidomide, and dexamethasone results from the real world continued to show effective responses and a tolerable safety profile. 

Submit a Comment

Your email address will not be published. Required fields are marked *